BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 20045594)

  • 21. Triptolide inhibits CC chemokines expressed in rat adjuvant-induced arthritis.
    Wang Y; Wei D; Lai Z; Le Y
    Int Immunopharmacol; 2006 Dec; 6(12):1825-32. PubMed ID: 17052673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of triptolide on aromatase activity in human placental microsomes and human placental JEG-3 cells.
    Zhang J; Jiang Z; Zhang L
    Arzneimittelforschung; 2011; 61(12):727-33. PubMed ID: 22282961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triptolide induces Bcl-2 cleavage and mitochondria dependent apoptosis in p53-deficient HL-60 cells.
    Wan CK; Wang C; Cheung HY; Yang M; Fong WF
    Cancer Lett; 2006 Sep; 241(1):31-41. PubMed ID: 16316721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f.
    Qiu D; Kao PN
    Drugs R D; 2003; 4(1):1-18. PubMed ID: 12568630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triptolide circumvents drug-resistant effect and enhances 5-fluorouracil antitumor effect on KB cells.
    Chen YW; Lin GJ; Chuang YP; Chia WT; Hueng DY; Lin CK; Nieh S; Sytwu HK
    Anticancer Drugs; 2010 Jun; 21(5):502-13. PubMed ID: 20154595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70.
    Phillips PA; Dudeja V; McCarroll JA; Borja-Cacho D; Dawra RK; Grizzle WE; Vickers SM; Saluja AK
    Cancer Res; 2007 Oct; 67(19):9407-16. PubMed ID: 17909050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Progress in research on triptolide].
    Liu MX; Dong J; Yang YJ; Yang XL; Xu HB
    Zhongguo Zhong Yao Za Zhi; 2005 Feb; 30(3):170-4. PubMed ID: 15719629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triptolide, A Potential Autophagy Modulator.
    Wei YM; Wang YH; Xue HQ; Luan ZH; Liu BW; Ren JH
    Chin J Integr Med; 2019 Mar; 25(3):233-240. PubMed ID: 30178091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triptolide inhibits interferon-gamma-induced programmed death-1-ligand 1 surface expression in breast cancer cells.
    Liang M; Fu J
    Cancer Lett; 2008 Nov; 270(2):337-41. PubMed ID: 18572307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells.
    Li H; Takai N; Yuge A; Furukawa Y; Tsuno A; Tsukamoto Y; Kong S; Moriyama M; Narahara H
    Cancer Lett; 2010 Nov; 297(2):198-206. PubMed ID: 20547442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental AA amyloidosis in mice is inhibited by treatment with triptolide, a purified traditional Chinese medicine.
    Cui D; Hoshii Y; Kawano H; Sugiyama S; Gondo T; Liu Y; Ishihara T
    Int Immunopharmacol; 2007 Sep; 7(9):1232-40. PubMed ID: 17630202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of triptolide on CD4+ and CD8+ cells in Peyer's patch of SD rats with collagen induced arthritis.
    Zhou J; Xiao C; Zhao L; Jia H; Zhao N; Lu C; Yang D; Tang JC; Chan AS; Lu AP
    Int Immunopharmacol; 2006 Feb; 6(2):198-203. PubMed ID: 16399624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The identity of immunosuppressive components of the ethyl acetate extract and chloroform methanol extract (T2) of Tripterygium wilfordii Hook. F.
    Tao X; Cai JJ; Lipsky PE
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1305-12. PubMed ID: 7891348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Advanced progress of main pharmacology activities of triptolide].
    Cui J; Chen X; Su JC
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(14):2655-2658. PubMed ID: 29098818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triptolide suppresses CD80 and CD86 expressions and IL-12 production in THP-1 cells.
    Liu J; Wu QL; Feng YH; Wang YF; Li XY; Zuo JP
    Acta Pharmacol Sin; 2005 Feb; 26(2):223-7. PubMed ID: 15663903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and structure-activity relationships studies on the D ring of the natural product triptolide.
    Xu H; Tang H; Feng H; Li Y
    ChemMedChem; 2014 Feb; 9(2):290-5. PubMed ID: 24339424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of vascular endothelial growth factor expression and production by triptolide.
    Hu KB; Liu ZH; Liu D; Li LS
    Planta Med; 2002 Apr; 68(4):368-9. PubMed ID: 11988867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effect of triptolide on lymph node metastasis in patients with non-Hodgkin lymphoma by regulating SDF-1/CXCR4 axis in vitro.
    Zhang C; Cui GH; Liu F; Wu QL; Chen Y
    Acta Pharmacol Sin; 2006 Nov; 27(11):1438-46. PubMed ID: 17049119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triptolide (PG-490) induces apoptosis of dendritic cells through sequential p38 MAP kinase phosphorylation and caspase 3 activation.
    Liu Q; Chen T; Chen H; Zhang M; Li N; Lu Z; Ma P; Cao X
    Biochem Biophys Res Commun; 2004 Jul; 319(3):980-6. PubMed ID: 15184078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triptolide, a diterpenoid triepoxide, induces antitumor proliferation via activation of c-Jun NH2-terminal kinase 1 by decreasing phosphatidylinositol 3-kinase activity in human tumor cells.
    Miyata Y; Sato T; Ito A
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1081-6. PubMed ID: 16176806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.